News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
142 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
2 (202)
3 (126)
4 (116)
5 (124)
6 (51)
9 (127)
10 (95)
11 (131)
12 (128)
13 (61)
16 (159)
17 (116)
18 (142)
19 (71)
20 (36)
23 (191)
24 (140)
25 (137)
26 (113)
27 (81)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
24
25
26
27
Regulatory
FDA Chief’s New Voucher Program Could Ease Biotech Investors’ Anxiety
Industry watchers responded mostly positively to the commissioner’s new voucher program, but worries remain over staffing cuts at the agency.
June 18, 2025
·
2 min read
·
Annalee Armstrong
Venture capitalists
More Than One-Third of Biotechs Have Under a Year of Cash Left, EY Finds
EY’s 2025 Biotech Beyond Borders report provides a sobering snapshot of the industry’s financial health, with more and more companies facing cash runways of less than one year. The analyst firm’s leaders urge a return to basics for biotech.
June 18, 2025
·
4 min read
·
Ana Mulero
Opinion
Recent Precedents Show Overseas Biosimilars Companies Can Be Sued in US
Findings that U.S. companies can sue foreign rivals despite limited business operations in the country could dissuade drug developers from targeting the U.S. market, potentially benefiting domestic producers of biosimilars.
June 18, 2025
·
3 min read
·
Mark Deming
Press Releases
Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
June 18, 2025
·
5 min read
Press Releases
Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
June 18, 2025
·
1 min read
Press Releases
Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence
June 18, 2025
·
3 min read
Press Releases
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
June 18, 2025
·
5 min read
Press Releases
Children’s Hospital of Philadelphia Receives Grant to Study Noninvasive Technique for Detecting Malaria Via Breathalyzer
June 18, 2025
·
4 min read
Press Releases
DNA Read, Write and Edit Market are Powering a $26.46 Billion Genomics Revolution
June 18, 2025
·
1 min read
Press Releases
Bristol Myers Squibb Announces Dividend - June 17, 2025
June 18, 2025
·
1 min read
Previous
2 of 15
Next